Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

61.42
BATS BZX Real-Time Price
As of 10:04am ET
 +0.56 / +0.92%
Today’s Change
50.71
Today|||52-Week Range
68.12
+3.68%
Year-to-Date
Leukemia Treatment Achieves Promising Results
Dec 05 / GuruFocus News - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
Why the $324 Billion Bioeconomy Deserves a Place in Your Portfolio
Nov 30 / MotleyFool.com - Paid Partner Content
FDA Orphan Drug Designation for AbbVie's Risankizumab
Dec 01 / GuruFocus News - Paid Partner Content
Testing of Treatment for Cystic Fibrosis Patients Begins
Nov 29 / GuruFocus News - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
Healthcare Stocks Help Nasdaq Reach New Heights
Nov 29 / TheStreet.com - Paid Partner Content
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar
Nov 30 / GuruFocus News - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content

Today’s Trading

Previous close60.86
Today’s open60.76
Day’s range60.39 - 61.53
Volume49,738
Average volume (3 months)7,272,740
Market cap$98.9B
Dividend yield4.17%
Data as of 10:04am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+12.35%
Earnings growth (next 5 years)+15.41%
Revenue growth (last year)+14.52%
P/E ratio16.6
Price/Sales4.24
Price/Book24.84

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.30+0.53%
GSKGlaxoSmithKline-0.13-0.35%
CELGCelgene+0.65+0.56%
SNYSanofi-0.73-1.78%
Data as of 10:04am ET, 12/06/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts


Search for Jobs